When you scan a food or supplement label, you might assume you’re seeing the most credible health information available. But what if some of the most authoritative, government-backed science is being kept off labels altogether?

In this episode of the Orange Pill Podcast, we unpack a new legal battle that’s putting the FDA’s regulatory authority, free speech, and consumer rights under the spotlight. At the center of the case is a surprising contradiction: claims drawn directly from research published by the NIH, CDC, and other federal health agencies are being blocked by the FDA from appearing on product labels.

We explore:
• Why the FDA is preventing companies from sharing government-authored health findings
• How a 1997 law was designed to allow these claims and why critics say the FDA overrode Congress
• Why this case is being framed as a First Amendment issue, not just a regulatory one
• How a recent Supreme Court ruling could dramatically shift the balance of power
• What this fight means for scientific transparency and informed consumer choice

This episode isn’t just about supplements. It’s about who gets to decide what health information reaches the public and whether consumers are being protected or restricted.